semaglutide step 5 2.4-mg Injection as a Novel Approach for Chronic Weight Management Another Weight-Loss Trial Win for

Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request

As our understanding of metabolic disease evolves, so does the recognition that successful care requires more than simply prescribing a medication

Importantly, these mechanistic hypotheses are supported by evidence from large, randomised controlled trials, which has demonstrated that GLP-1RAs reduced major adverse cardiovascular events (MACE), including myocardial infarction, stroke and cardiovascular death, particularly in high-risk individuals such as those with type 2 diabetes mellitus

It also helps to stop elastin from getting destroyed